FindTrial
Sign In

Effectiveness of acetylcysteine in first line therapy to cure Helicobacter pylori. Pilot study. - ND

Effectiveness of acetylcysteine in first line therapy to cure Helicobacter pylori. Pilot study. - ND

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2009-011978-15-IT
Enrollment
Unknown
Registered
2009-04-20
Start date
2010-02-22
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

peptic, duodenal and gastric ulcer with Helicobacter pylori infection MedDRA version: 9.1 Level: LLT Classification code 10051790 MedDRA version: 9.1 Level: LLT Classification code 10065231

Interventions

Trade Name: ACETILCISTEINA*20CPR EFF 600MG Pharmaceutical Form: Effervescent tablet INN or Proposed INN: Acetylcysteine Concentration unit: mg milligram(s) Concentration type: equal Concentration numb

Sponsors

POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: both genders, age > 18 years, infection from Helicobacter pylori, at gastroscopy or 13C urea breath test. Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Verified allergies to the acetylcysteine or to the antibiotics to cure Helicobacter pylori, pregnancy, nursing.

Design outcomes

Primary

MeasureTime frame
Main Objective: Effectiveness of acetylcysteine in first line therapy to cure Helicobacter pylori. Due to lytic action on the gastric mucus, the administration of acetylcysteine in the 7 preceding days the first line therapy would allow a best aggression of the Helicobacter from the usual antibiotic.;Secondary Objective: ND;Primary end point(s): Helicobacter pylori eradication—

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026